Results 121 to 130 of about 26,112 (181)

Association Between rs2278426 Polymorphism of the ANGPTL8 Gene and Polycystic Ovary Syndrome

Diabetes, Metabolic Syndrome and Obesity
Han Wu,1,* Hui Wang,2,* Lixia Sun,3,* Mengchen Liu,1 Haoran Wang,1 Xianchang Sun,4 Wenjuan Zhang1 1Center for Reproductive Medicine, The Second Affiliated Hospital of Shandong First Medical University, Taian, 271000, People’s Republic of ...
Wu H, Wang H, Sun L, Liu M, Wang H, Sun X, Zhang W   +6 more
doaj  

Distinct Roles of Myeloid‐ and Hepatocyte‐PLA2G6 Deletion in Mice With Metabolic Dysfunction‐Associated Steatotic Liver Disease

Liver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background and Aims Polymorphisms of group VIA calcium‐independent phospholipase A2 (iPLA2β or PLA2G6) are associated with Type‐2 diabetes, blood lipids and inflammation. Global deficiency in iPLA2β‐null mice elicited protection against hepatic steatosis but not hepatic inflammation after high‐fat diet (HFD) feeding.
Gang Li, Simone Staffer, Sabine Tuma‐Kellner, Uta Merle, Walee Chamulitrat   +4 more
wiley   +1 more source

From Theory to Practice: Which Biomarkers Are Ready for Predicting Response in Advanced HCC?

Liver International, Volume 46, Issue 6, June 2026.
ABSTRACT Systemic therapies for advanced hepatocellular carcinoma (HCC) have expanded considerably with the advent of tyrosine kinase inhibitors, immune checkpoint inhibitors and immunotherapy–anti‐angiogenic combinations. However, despite this therapeutic diversification, first‐line treatment selection remains largely empirical, as few biomarkers are ...
Marie Decraecker, Jean‐Frédéric Blanc, Samuel Amintas, Grégoire Manaud   +3 more
wiley   +1 more source

Angiopoietin-like protein 8 [PDF]

, 2019
openaire   +1 more source

A comparison of plasma Tsukushi in adolescents with and without metabolic dysfunction‐associated steatotic liver disease

Physiological Reports, Volume 14, Issue 12, June 2026.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common liver disease in children and adolescents. Assessment of circulating biomarkers is needed to understand the underlying pathology, disease severity, and treatment options.
Sydni A. McNeese, Sadie A. Maltz, Youngsil Kim, April M. Teague, Sirish K. Palle, Jacob E. Friedman, Kevin R. Short   +6 more
wiley   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein-Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome? [PDF]

Int J Mol Sci, 2020
Krahel JA, Baran A, Kamiński TW, Flisiak I.   +3 more
europepmc   +1 more source

Loss of Glycine N-Methyltransferase Associates with Angiopoietin-Like Protein 8 Expression in High Fat-Diet-Fed Mice. [PDF]

Int J Mol Sci, 2019
Huang JW, Chen CJ, Yen CH, Chen YA, Liu YP.   +4 more
europepmc   +1 more source

Impact of Tumor Necrosis Factor Antagonist Therapy on Circulating Angiopoietin-like Protein 8 (ANGPTL8) Levels in Crohn's Disease-A Prospective Multi-Center Study. [PDF]

J Clin Med
Shehab M, Al-Fajri S, Alanqar A, Alborom M, Alrashed F, Alshammaa F, Alfadhli A, Devarajan S, Alkhairi I, Cherian P, Abubaker J, Abu-Farha M, Al-Mulla F.   +12 more
europepmc   +1 more source

The potential role of angiopoietin-like protein-8 in type 2 diabetes mellitus: a possibility for predictive diagnosis and targeted preventive measures? [PDF]

EPMA J, 2019
Issa YA, Abd ElHafeez SS, Amin NG.
europepmc   +1 more source

Predictive value of angiopoietin-like protein 8 in metabolic dysfunction-associated fatty liver disease and its progression: A case-control study. [PDF]

World J Diabetes
Gan LL, Xia C, Zhu X, Gao Y, Wu WC, Li Q, Li L, Dai Z, Yan YM.   +8 more
europepmc   +1 more source